FDA approvals for the first 6 months of 2017

The US FDA approved 23 new drugs in the first 6 months of 2017 (Table 1). This is more than the agency approved in the entirety of 2016, a lacklustre year with only 22 approvals (Nat. Rev. Drug Discov. 16, 73–76; 2017).

Table 1 FDA approvals in the first 6 months of 2017

The FDA tends to approve more drugs in the second half of the year than in the first, but this is not always the case. In 2016, it approved 13 in the first half of the year and the other 9 in the second.

Authors

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. FDA approvals for the first 6 months of 2017. Nat Rev Drug Discov 16, 519 (2017). https://doi.org/10.1038/nrd.2017.148

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing